Support the news

Moderna Therapeutics Launches IPO03:42

This article is more than 1 year old.

A Boston-based biotech company is about to go public. Moderna Therapeutics has raised millions of dollars privately as it tries to develop a synthetic version of the "messenger molecules" — mRNA — in the human body that communicate instructions to the body's cells.

Damian Garde of STAT joined Bob Oakes on Morning Edition to discuss the Initial Public Offering (IPO) from Moderna, which is reportedly the biggest IPO in medical tech history.

This segment aired on December 7, 2018.

Bob Oakes Twitter Host, Morning Edition
Bob Oakes has been WBUR's Morning Edition anchor since 1992.


+Join the discussion

Support the news